Journal Club of the Week: The role of Tyrosine Kinase Inhibitors in Cancer Therapy

The topic for today journal club meeting (29-06-2015) was "The role of Tyrosine Kinase Inhibitors in Cancer Therapy". During the lecture, Dr. Haji Bahadar introduced the participants to the Tyrosine Kinase Receptors, Tyrosine Kinase Inhibitors and their potential use in the cancer therapy instead of conventional cancer therapies. He also discussed some important inhibitors, which are FDA approved and in the market. Furthermore, he also threw light on the mechanism involved in this specific targeted therapy. The meeting became fruitful by the participation of the audience in criticizing the topic and discussion on various aspects of TINIBS as new targeted therapies.